Cite

HARVARD Citation

    Shetty, K. et al. (2014). Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma. Journal of transplantation. p. . [Online]. 
  
Back to record